[{"Assets_0_Q1_USD":"112435000000.0","CIK":"14272","CommonStockDividendsPerShareDeclared_1_Q1_USD":"0.49","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.9","EarningsPerShareDiluted_1_Q1_USD":"0.89","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","Market Cap":"162365000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"3824000000.0","NetIncomeLossConverted_1_Q1_USD":"2021000000.0","OfficialName":"Bristol-Myers Squibb Company Common Stock","RevenuesConverted_1_Q1_USD":"11073000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"37673000000.0","StockholdersEquity_0_Q1_USD":"37605000000.0","Ticker":"BMY","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"2265000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"2236000000.0","filed":"20210429","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"BRISTOL MYERS SQUIBB CO","period":"20210331","qtrs":"1","uom":"USD"}]